Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Submitted by
admin
on May 17, 2010 - 10:36am
Source:
Street Insider
News Tags:
Amgen
BLA
FDA
denosumab
RANK Ligand inhibitor
Headline:
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Do Not Allow Advertisers to Use My Personal information
